Bioneer – Park Han-Oh, Founder and CEO – South Korea
11.12.2014
Related Interviews
Stephen Yoo – CEO & CSO, STCube Pharmaceuticals
Stephen Yoo highlights the pioneering work that STCube Pharmaceuticals – a US subsidiary of Korean firm STCube – is undertaking in the immuno-oncology field, its three technology platforms, partnership approach,…
Korea / Exploring the Regenerative and Anti-Inflamatory Potential of Exosomes
ExoCoBio’s CEO, Byong Seung Cho, went from biotech venture capital to setting up ExoCoBio, a company whose core technology is based on adipose stem-cell derived exosomes for regenerative medicine and…
Exclusive / Samsung Biologics CEO Talks 35% Annual Growth, CDMO Industry Trends & Korea's BioInnovation Agenda
After a dynamic two years as CEO of Samsung Biologics, John Rim highlights some of the fundamentals behind the company’s rapid growth as a CDMO, including the creation of huge…
Leadership / Bill Sibold Swaps Sanofi for Biotech Seeking First NASH FDA Approval
After a 12-year stint at Sanofi, Bill Sibold is leaving Big Pharma to join the Pennsylvania-based biotech Madrigal Pharmaceuticals as CEO. Sibold, no stranger to ground-breaking launches, having brought the…
MEA / Clinical Research in the UAE: Quickfire Progress & The Road Left to Travel
With cutting-edge hospital infrastructure being put in place, government authorities rolling out evermore supportive regulatory upgrades, big pharma championing ‘clinical trial diversity’ with greater non-Caucasian representation in trial cohorts, and…
Global / Top Five CROs 2023
The global contract research organization (CRO) market is estimated to be worth USD 76.6 billion in 2023 and is projected to reach USD 127.3 billion by 2028, growing at a…
